Equilliumbio.com

Equilliumbio.com has Server used 34.94.125.179 IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2017-05-16 (4 years, 68 days) and hosted in Houston United States, server ping response time 103 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Equilliumbio keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Equilliumbio
2 Equilliumbio.com

Hosting Provider

Website: Equilliumbio.com
Hostname: 179.125.94.34.bc.googleusercontent.com
Country:
Region: TX
City: Houston
Postal Code: 77072
Latitude: 29.699699401855
Longitude: -95.585800170898
Area Code: 281
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Buycials.com (16 seconds ago)

   » Exterraresources.com (21 seconds ago)

   » Cajola.com (2 seconds ago)

   » Expertvoice.com (1 seconds ago)

   » Jacars.net (5 seconds ago)

   » Amerisure.com (19 seconds ago)

   » Balibookingtour.com (13 seconds ago)

   » Allaccessmusicschool.com (5 seconds ago)

   » Thematrixwand.com (2 seconds ago)

   » Askromapadaswami.com (3 seconds ago)

Results For Websites Listing

Found 47 Websites with content related to this domain, It is result after search with search engine

Equillium, Inc. (EQ) Stock Price, News, Quote & History

Finance.yahoo.com   DA: 17 PA: 10 MOZ Rank: 27

About EquilliumEquillium is a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products to treat severe autoimmune and inflammatory disorders

EQ Stock Price Equillium Inc. Stock Quote (U.S.: Nasdaq

Marketwatch.com   DA: 19 PA: 19 MOZ Rank: 39

  • engages in the development of products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need

EQ Stock Forecast, Price & News (Equillium) MarketBeat

Marketbeat.com   DA: 18 PA: 18 MOZ Rank: 38

  • Equillium's stock was trading at $3.50 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO)
  • Since then, EQ stock has increased by 58.3% and is now trading at $5.54
  • View which stocks have been most impacted by COVID-19
  • What price target have analysts set for EQ?

Equillium Inc (EQ : NASDAQ) Stock Price & News

Google.com   DA: 14 PA: 24 MOZ Rank: 41

  • The difference between the high and low prices over the past day

Equillium Inc (EQ) Quote

Morningstar.com   DA: 19 PA: 21 MOZ Rank: 44

  • Equillium Inc is a biopharmaceutical company
  • It is developing novel immune-modifying therapies for severe immuno-inflammatory diseases.

Equilliumbio.gcs-web.com

Equilliumbio.gcs-web.com   DA: 24 PA: 24 MOZ Rank: 53

  • Equillium is a biotechnology company leveraging deep understanding of immunobiology to develop products for autoimmune and inflammatory disorders, or immuno-inflammation, with high unmet medical need
  • Our initial product candidate, EQ001, is a first-in-class monoclonal antibody that selectively targets the novel immune

Equillium, Inc. LinkedIn

Linkedin.com   DA: 16 PA: 18 MOZ Rank: 40

Equillium is a clinical-stage biotechnology company leveraging deep understanding of immunobiology to pioneer new products with a mission to dramatically improve the lives of patients with severe

Equillium Announces Successful Completion Of FDA Pre-IND

Globenewswire.com   DA: 21 PA: 50 MOZ Rank: 78

Equillium is a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products to treat severe autoimmune and inflammatory disorders …

Equillium To Present At The JMP Securities Life Sciences

Globenewswire.com   DA: 21 PA: 50 MOZ Rank: 79

Equillium is a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products to treat severe autoimmune and …

Equillium (NasdaqGM:EQ)

Simplywall.st   DA: 13 PA: 50 MOZ Rank: 72

Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need.

Equillium Announces Successful Completion Of FDA Pre-IND

Nasdaq.com   DA: 14 PA: 50 MOZ Rank: 74

Investor ContactChristine Zedelmayer, Chief Operating [email protected]equilliumbio.com Media Contact Cammy Duong Canale Communications +1-619-849-5389 [email protected] Equillium

Equillium : Announces Positive Topline Results From The

Marketscreener.com   DA: 22 PA: 50 MOZ Rank: 83

  • For more information, visit www.equilliumbio.com
  • Forward Looking Statements Statements contained in this press release regarding matters that are not historical facts are 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995.

Equillium To Present At The Jefferies Virtual Healthcare

Biospace.com   DA: 16 PA: 50 MOZ Rank: 78

  • For more information, visit www.equilliumbio.com
  • Investor Contact Michael Moore Vice President, Investor Relations & Corporate Communications +1-619-302-4431 [email protected]equilliumbio.com
  • Media Contacts Aljanae Reynolds Wheelhouse Life Science Advisors [email protected]

Orthohealing.com 313 Days Left

Site-stats.org   DA: 14 PA: 18 MOZ Rank: 45

  • Orthohealing.com Creation Date: 2008-05-20 | 313 days left
  • Register domain GoDaddy.com, LLC store at supplier Google LLC with ip address 34.94.125.179

Equillium : Announces Plans To Initiate Phase 3 Pivotal

Marketscreener.com   DA: 22 PA: 50 MOZ Rank: 86

  • For more information, visit www.equilliumbio.com
  • Forward Looking Statements Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.

Equillium To Host Conference Call Following Presentation

Bloomberg.com   DA: 17 PA: 50 MOZ Rank: 82

About Equillium Equillium is a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products to …

Equillium To Present At The Jefferies Virtual Healthcare

Marketwatch.com   DA: 19 PA: 50 MOZ Rank: 85

  • LA JOLLA, May 26, 2021 (GLOBE NEWSWIRE via COMTEX) -- LA JOLLA, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- Equillium, Inc

Tom Boone Biologics CMC Consulting Pharmefex

Pharmefex.com   DA: 17 PA: 10 MOZ Rank: 44

  • Tom was the lead scientist in the development of Nplate®, a treatment of thrombocytopenia
  • His critical role in the discovery and process development of G-CSF (Neupogen) is widely recognized
  • Tom has recently helped start several companies and has helped them license in clinical stage molecules
  • He is also currently a consultant or scientific

Equillium To Host Conference Call Following Presentation

Biospace.com   DA: 16 PA: 50 MOZ Rank: 84

Equillium is a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products to treat severe autoimmune and inflammatory disorders with high unmet medical need.

Investor Summit Group

Events.investorbrandnetwork.com   DA: 31 PA: 29 MOZ Rank: 79

  • The Investor Summit Group will continue helping microcap businesses form vital funding relationships in the COVID-19 age by demonstrating its concierge experience in an online format in June
  • The Virtual Summer Summit will help devote resources to both businesses and investors, taking the stress out of finding the right connections
  • As Investor Summit organizes companies' schedules with

Equillium To Present At BTIG Virtual Biotechnology

Nasdaq.com   DA: 14 PA: 50 MOZ Rank: 84

Christine Zedelmayer, Chief Operating [email protected]equilliumbio.com Media Contact Cammy Duong Canale Communications …

Equillium Announces Positive Topline Results From The

Tmcnet.com   DA: 14 PA: 31 MOZ Rank: 66

  • For more information, visit www.equilliumbio.com
  • Forward Looking Statements Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.

Equillium, Inc. (Form: 8-K, Received: 11/12/2019 16:12:19)

Content.edgar-online.com   DA: 24 PA: 45 MOZ Rank: 91

  • For more information, visit www.equilliumbio.com
  • Executive Biographies Bruce Steel is a co-founder and director of Equillium, and has served as its president and chief business officer since June 2018 and a member of the Board since March 2017
  • Prior to Equillium Bruce was the founder and managing director of BioMed Ventures, the strategic

Biotech Catalyst Calendars And Drug Pipelines

Biopharmcatalyst.com   DA: 24 PA: 16 MOZ Rank: 63

  • For more information, visit www.equilliumbio.com
  • Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.

Equillium Announces Positive Topline Results From The

Benzinga.com   DA: 16 PA: 50 MOZ Rank: 90

Equillium Announces Plans To Initiate Phase 3 Pivotal

Tmcnet.com   DA: 14 PA: 50 MOZ Rank: 89

  • For more information, visit www.equilliumbio.com
  • Forward Looking Statements Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.

Equillium To Present At The H.C. Wainwright Virtual

Benzinga.com   DA: 16 PA: 50 MOZ Rank: 92

  • Vice President, Investor Relations & Corporate Communications

Equillium, Inc. (Form: 8-K, Received: 10/01/2019 16:11:47)

Content.edgar-online.com   DA: 24 PA: 45 MOZ Rank: 96

Equillium, Inc.2223 Avenida de la Playa / Suite 105La Jolla, CA 92037www.equilliumbio[email protected]equilliumbio.com EXHIBIT 99.2 Equillium Announces Initiation of the EQUALISE Phase 1b Clinical Trial of Itolizumab for Patients with …

Equillium To Host Conference Call Following Presentation

Morningstar.com   DA: 19 PA: 50 MOZ Rank: 97

  • For more information, visit www.equilliumbio.com
  • Investor Contact Michael Moore Vice President, Investor Relations & Corporate Communications 619-302-4431 [email protected]equilliumbio.com.

Equillium VentureRadar

Ventureradar.com   DA: 20 PA: 50 MOZ Rank: 99

"Equillium is a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products to treat severe autoimmune and …

Equillium, Inc. 8-K Nov. 25, 2020 8:01 AM Seeking Alpha

Seekingalpha.com   DA: 16 PA: 15 MOZ Rank: 61

  • Katherine Carlyle Smith Senior Account Associate Canale Communications +1-805-907-2497
  • [email protected]

Company Details :: Pink Sheet

Pink.pharmaintelligence.informa.com   DA: 35 PA: 15 MOZ Rank: 81

Biocon chair believes new perspectives on regulatory science and processes emerging from the US's "Warp Speed" efforts to accelerate COVID-19 vaccines have potential for wider application, although Regeneron's president urges caution around relying only on small studies to advance repurposed drugs.

Working At Equillium Glassdoor

Glassdoor.com   DA: 17 PA: 50 MOZ Rank: 99

  • Glassdoor gives you an inside look at what it's like to work at Equillium, including salaries, reviews, office photos, and more
  • This is the Equillium company profile.

Equillium Announces Positive Interim Data With Itolizumab

Stem-cells.in-the.news   DA: 22 PA: 50 MOZ Rank: 17

  • For more information, visit www.equilliumbio.com
  • Forward Looking Statements Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.

Equillium 2223 Avenida De La Playa, La Jolla, CA 92037

Yellowpages.com   DA: 19 PA: 36 MOZ Rank: 89

  • Do you know the hours for this business? Extra Phones

Equillium, Inc. (EQ) Company Profile & Facts

Ca.finance.yahoo.com   DA: 20 PA: 18 MOZ Rank: 73

  • See the company profile for Equillium, Inc
  • (EQ) including business summary, industry/sector information, number of employees, business summary, corporate governance, key …

Recently Analyzed Sites

Buycials.com (17 seconds ago)

Exterraresources.com (22 seconds ago)

Cajola.com (3 seconds ago)

Expertvoice.com (2 seconds ago)

Jacars.net (6 seconds ago)

Amerisure.com (20 seconds ago)

Apexhealthcare.net (1 seconds ago)

Allaccessmusicschool.com (6 seconds ago)

Thematrixwand.com (3 seconds ago)

Askromapadaswami.com (4 seconds ago)

Best174.biz (2 seconds ago)

Longbeachcalsoap.org (14 seconds ago)

Equilliumbio.com (1 seconds ago)

4americaschildren.org (10 seconds ago)

Libertyvillagedental.com (0 seconds ago)

Midmarylandhomefinder.com (10 seconds ago)

Rnestudio.com (5 seconds ago)

Itsugar.com (12 seconds ago)